Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Jingwei Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5341-2776; OpenAlex author ID A5100416937. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper

Papers 2

  1. Gasdermin C promotes Stemness and Immune Evasion in Pancreatic Cancer via Pyroptosis-Independent Mechanism. First author DOI 10.1002/advs.202308990↗
  2. A novel pyroptosis-associated lncRNA LINC01133 promotes pancreatic adenocarcinoma development via miR-30b-5p/SIRT1 axis. Co-author DOI 10.1007/s13402-023-00818-5↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Da Fu · 2 shared papers, 2023–2024 · strength 0.37
  2. Jiewei Lin · 1 shared paper, 2023 · strength 0.20
  3. Yuchen Ji · 1 shared paper, 2023 · strength 0.20
  4. Weishen Wang · 1 shared paper, 2023 · strength 0.20
  5. Baiyong Shen · 1 shared paper, 2023 · strength 0.20
  6. Berina Šabanović · 1 shared paper, 2024 · strength 0.17
  7. Renfei Wu · 1 shared paper, 2024 · strength 0.17
  8. Quan Zheng · 1 shared paper, 2024 · strength 0.17
  9. Lingxi Jiang · 1 shared paper, 2024 · strength 0.17
  10. Chenlei Wen · 1 shared paper, 2024 · strength 0.17
  11. Christopher Heeschen · 1 shared paper, 2024 · strength 0.17
  12. Baiyong Shen · 1 shared paper, 2024 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.